Marion Biotech
- All
- News
- Videos
-
Indian Among 21 Sentenced In Uzbekistan Over Cough Syrup Deaths
Uzbekistan on Monday handed out sentences to 21 people linked to the deaths of 68 children who consumed a contaminated cough syrup produced in India.
-
Uzbekistan Syrup Deaths: Noida Firm's Licence Cancelled By Uttar Pradesh
The manufacturing licence of Noida-based pharmaceutical firm Marion Biotech was cancelled on Wednesday by Uttar Pradesh authorities, according to officials.
-
After Uzbekistan Syrup Deaths, Regulator's Big Move Against Delhi Firm
India's drug regulator directed drug manufacturers not to use propylene glycol supplied by a Delhi-based company which provided the ingredient to Marion Biotech, whose cough syrups were alleged to have led to the deaths of children in Uzbekistan.
-
Uzbekistan Syrup Deaths: Process Initiated To Cancel Noida Firm's Licence
The process has been initiated for cancellation of the drug licence of pharmaceutical firm Marion Biotech, which is allegedly linked with the death of 18 children in Uzbekistan who consumed their cough syrup in December 2022, officials in Noida said.
-
Uzbekistan Child Deaths: 3 Employees Of Noida-Syrup Manufacturer Arrested
Cough Syrup Deaths: The Noida Police on Friday arrested three employees of a city-based pharmaceutical firm whose cough syrup is alleged to have led to the death of 18 children in Uzbekistan last year, officials said.
-
Uzbekistan Child Deaths: Noida Syrup Manufacturer's Licence Suspended
The production licence of Noida-based pharmaceutical firm Marion Biotech, allegedly linked with the deaths of children in Uzbekistan, has been suspended while the test results of its controversial cough syrup are awaited, an UP drug official said.
-
"Substandard": WHO Alert On 2 Indian Syrups After Uzbekistan Child Deaths
The World Health Organisation (WHO) has recommended that two cough syrups made by Noida-based company Marion Biotech should not be used for children in Uzbekistan.
-
Noida Firm Behind Syrup Linked To 18 Uzbekistan Deaths To Halt All Production
A deviation from schedule M of Good Manufacturing Practice (GMP), a system for ensuring that products are consistently produced and controlled according to quality standards, was observed at Marion's plant.
-
Indian Among 21 Sentenced In Uzbekistan Over Cough Syrup Deaths
Uzbekistan on Monday handed out sentences to 21 people linked to the deaths of 68 children who consumed a contaminated cough syrup produced in India.
-
Uzbekistan Syrup Deaths: Noida Firm's Licence Cancelled By Uttar Pradesh
The manufacturing licence of Noida-based pharmaceutical firm Marion Biotech was cancelled on Wednesday by Uttar Pradesh authorities, according to officials.
-
After Uzbekistan Syrup Deaths, Regulator's Big Move Against Delhi Firm
India's drug regulator directed drug manufacturers not to use propylene glycol supplied by a Delhi-based company which provided the ingredient to Marion Biotech, whose cough syrups were alleged to have led to the deaths of children in Uzbekistan.
-
Uzbekistan Syrup Deaths: Process Initiated To Cancel Noida Firm's Licence
The process has been initiated for cancellation of the drug licence of pharmaceutical firm Marion Biotech, which is allegedly linked with the death of 18 children in Uzbekistan who consumed their cough syrup in December 2022, officials in Noida said.
-
Uzbekistan Child Deaths: 3 Employees Of Noida-Syrup Manufacturer Arrested
Cough Syrup Deaths: The Noida Police on Friday arrested three employees of a city-based pharmaceutical firm whose cough syrup is alleged to have led to the death of 18 children in Uzbekistan last year, officials said.
-
Uzbekistan Child Deaths: Noida Syrup Manufacturer's Licence Suspended
The production licence of Noida-based pharmaceutical firm Marion Biotech, allegedly linked with the deaths of children in Uzbekistan, has been suspended while the test results of its controversial cough syrup are awaited, an UP drug official said.
-
"Substandard": WHO Alert On 2 Indian Syrups After Uzbekistan Child Deaths
The World Health Organisation (WHO) has recommended that two cough syrups made by Noida-based company Marion Biotech should not be used for children in Uzbekistan.
-
Noida Firm Behind Syrup Linked To 18 Uzbekistan Deaths To Halt All Production
A deviation from schedule M of Good Manufacturing Practice (GMP), a system for ensuring that products are consistently produced and controlled according to quality standards, was observed at Marion's plant.
